Investors & Board

INVESTORS

Medicyte has previously secured investments from the Prinz von Hohenzollern Capital GmbH & Co. KG, private investor Dr. Björn F. Lindemann and the Kreditanstalt für Wiederaufbau (KfW).

SUPERVISORY BOARD

Andreas Schuster (chairman), Managing Director Prinz von Hohenzollern Capital
Prof. Dr. Jan-Heiner Küpper, Professor for molecular cell biology
Dr. Björn F. Lindemann, Biotech Entrepreneur